Contents of this document
- Higher raw-material prices¥122 100 million
- Impairment losses in the CNT dispersion business and other businesses¥92 100 million
- Gain on sale of securities¥51 100 million
- Expected additional gain on the sale of investment securities¥86 100 million
- Acquisition of treasury shares held by TOPPAN Holdings Co., Ltd.
- Cancellation of 9 million treasury shares
- Phased sale of 12,984,524 TOPPAN Holdings shares held by the company
- Overseas sales ratio56.4 %Year on year against the same period last year+1.4%
- Equity ratio58 %Year on year against the same period last year+0.5%
- D/E ratio0.3 timesYear on year against the same period last year-0.0%
- Number of consolidated subsidiaries56 companiesYear on year against the same period last year0.0%
- Number of equity-method affiliates5 companiesYear on year against the same period last year0.0%
| Item | Details |
|---|---|
| Document type | Supplementary materials to the earnings summary |
| Fiscal Period Covered | Q3 of the fiscal year ending December 2026 |
| Net Sales | ¥2,905 100 million (YoY +12.4%) |
| Operating profit | ¥204 100 million (YoY +36.8%) |
| Ordinary income | ¥219 100 million (YoY +51.8%) |
| Net income | ¥94 100 million (YoY -2.4%) |
| Operating profit margin | 7 |
| Results for the three months of the current quarter | Net Sales ¥1,009 100 million (YoY +12.5%) / Operating profit ¥78 100 million (YoY +41.4%) |
| Full-year earnings forecast | Net Sales ¥3,880 100 million / Operating profit ¥260 100 million / Ordinary income ¥275 100 million / Profit attributable to owners of the parent ¥190 100 million |
| Segment results | Colorants and Functional Materials Net Sales ¥657 100 million (YoY +3.9%) / Operating profit ¥30 100 million (YoY +117.1%) / Polymers and coating Net Sales ¥771 100 million (YoY +15.5%) / Operating profit ¥77 100 million (YoY +30.4%) / Package Net Sales ¥799 100 million (YoY +18.2%) / Operating profit ¥59 100 million (YoY +51.0%) / Printing and information Net Sales ¥662 100 million (YoY +11.1%) / Operating profit ¥37 100 million (YoY +15.0%) / Other Net Sales ¥53 100 million (YoY +32.0%) / Operating profit ¥0 100 million |
| Breakdown of Factors Affecting the Change | Factors Higher raw-material prices / Amount ¥122 100 million, Factors Impairment losses in the CNT dispersion business and other businesses / Amount ¥92 100 million, Factors Gain on sale of securities / Amount ¥51 100 million, Factors Expected additional gain on the sale of investment securities / Amount ¥86 100 million |
| Key KPIs | Indicator name Overseas sales ratio / Value 56.4 % / Year on year against the same period last year 1.4 %, Indicator name Equity ratio / Value 58 % / Year on year against the same period last year 0.5 %, Indicator name D/E ratio / Value 0.3 times / Year on year against the same period last year -0.02 times, Indicator name Number of consolidated subsidiaries / Value 56 companies / Year on year against the same period last year 0 companies, Indicator name Number of equity-method affiliates / Value 5 companies / Year on year against the same period last year 0 companies |
| Annual Dividend | Annual dividend per share ¥120 per share / Interim ¥60 per share / Full-year forecast ¥60 per share |
| Acquisition of treasury shares | Target All shares of the company owned by TOPPAN Holdings Co., Ltd. (22.28%) / Acquisition price Not disclosed / Number of shares to be acquired Not disclosed / Number of shares cancelled 900 10,000 shares / Period Not disclosed |
| New initiatives | Acquisition of treasury shares held by TOPPAN Holdings Co., Ltd., Cancellation of 9 million treasury shares, Phased sale of 12,984,524 TOPPAN Holdings shares held by the company |
Items this document does not state (16)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue, operating income and ordinary income were revised upward as sales volumes, expanded sales and price revisions progressed relatively smoothly. Net income for the fiscal year was revised downward due to the impact of a ¥9.2 billion impairment loss arising from worsening business conditions in businesses including the CNT dispersion business for LiB applications and deteriorating profitability in Turkey.